Skip to content

Clinical trials

Observational Renal Insufficiency, Chronic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Observational Country / region: Canada Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20089
20112
20122
20141
20162
20171
20181
20192
20203
20214
20225
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting9
Recruiting6
Unknown status6
Terminated2
Enrolling by invitation1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's10
Bayer3
University Health Network, Toronto3
University of British Columbia3
AstraZeneca2
Ciusss de L'Est de l'Île de Montréal2
The Hospital for Sick Children2
University of Alberta2
University of Manitoba2
Children's Hospital of Philadelphia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic41
Cardiovascular Diseases4
Diabetes Mellitus4
Diabetes Mellitus, Type 24
Hypertension4
Acute Kidney Injury3
Drug-Related Side Effects and Adverse Reactions3
Heart Failure3
Kidney Failure, Chronic3
Anxiety Disorders2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.